Esperion Therapeutics (2)
Pre-clinicalEsperion is dedicated to discovering, developing and commercializing innovative and combination medicines to reduce cardiovascular risk.
Founded
1998
Focus
Microbiome
About
Esperion is dedicated to discovering, developing and commercializing innovative and combination medicines to reduce cardiovascular risk.
Company Info
TypePrivate
Founded1998
LocationAnn Arbor, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile